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Abstract
Introduction: Ameloblastoma is the most common benign tumor of 
odontogenic origin, and represents about 11% of all odontogenic tumors. 
It is characterized by being locally aggressive and having high recurrence 
rates. Objective: To evaluate the occurrence of ameloblastoma in the 
Erasto Gaertner Hospital in patients from 1972 to 2012. In addition, to 
assess the main treatments, the most prevalent histological variants, the 
recurrence rate, the anatomical location of the lesion and patient profile. 
Material and methods: A retrospective study of patients diagnosed 
with ameloblastoma at the Erasto Gaertner Hospital between the years 
1972-2012 was performed. Epidemiological data were collected such as 
gender, age, race, lesion location, type of surgical procedure, follow-up 
and recurrence rate; and analyzed using descriptive statistics. Results: 
A total of 40 patients were selected for the study. The most affected 
age group was between the third and fifth decade of life, with 19 cases 
(47.5%), followed by the second and fourth decade, with 14 cases (35%); 
the sixth decade, with 5 cases (12.5%) and seventh decade with 1 case 
(2.5%). The patients’ ages ranged from 13 to 66 years, with an average 
age 34.9 years. The mandible was the most affected site, with 38 cases 
(95%) of cases, and maxilla had only 2 cases (5%). Thirty-eight patients 
were treated with radical surgery and 5 patients presented recurrence 
after 1 year of follow-up. Both cases that occurred in maxilla presented 
recurrence. Conclusion: Recurrence of ameloblastoma decreases 
significantly when surgery is performed properly, with wide excision and 
margin. Combination of full tumor resection and reconstruction was 
the best approach observed in this study. In addition, we recommend 
a long period of clinical and radiographic follow-up.
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Introduction
The ameloblastoma is the most common 
benign tumor of epithelial odontogenic origin, and 
represents about 11% of all odontogenic tumors 
[3]. It originates from epithelial remnants of intra 
and/or extra-osseous location [6]. Characterized by 
slow and painless swelling is often diagnosed due 
to increased local volume or by means of routine 
radiographs [11].
Radiographically it can appear as unilocular or 
multilocular radiolucent images, with bone erosion. 
It may be associated with impacted teeth and cause 
radicular resorption [19]. The most frequent location 
is posterior mandible, but it is rarely found in the 
maxilla, where the prognosis is much worse due 
to increased infiltration of trabecular bone and 
anatomic location [4]. The peak incidence occurs 
at the third and fourth decades of life with equal 
gender distribution [14]. 
The high recurrence rates remain problematic, 
and several factors have been identified, such as 
clinicopathologic variant and anatomical location 
[12]. The occurrence in maxilla, due bone porosity, 
facilitates the spread of the tumor [4], that behaves 
more aggressively than in the mandible [2]. 
Treatment for  a meloblastoma may be 
conservative or radical. The conservative technique 
includes enucleation and/or curettage. The radical 
treatment includes partial or marginal resection 
associated with chemical (Carnoy’s solution) or 
thermal (cryotherapy)adjuvant treatment.
While conservative therapies may be presented 
as less morbid for patients, there are increased risk 
of recurrence in such treatment. For that reason, 
radical treatments have lower rates of recurrence 
and constitute the vast majority of cases [15], but 
this choice often requires bone reconstruction to 
restore function and aesthetics [24].
The aim of this study was to establish an 
epidemiological profile of ameloblastoma in the 
hospital, between the years of 1972 and 2012, assess 
the main treatments, the relapse rate, anatomic 
location of the lesion, and the patient’s profile.
Material and methods
A retrospective study was conducted with patients 
with diagnosis of ameloblastoma referred to the 
Service of Oral and Maxillofacial Surgery of the Erasto 
Gaertner Hospital between the years of 1972-2012. 
Epidemiological data were collected such as gender, 
age, race, lesion location, type of surgical procedure, 
follow-up and recurrence rate. The study excluded 
patients with follow-up less than 12 months.
Results
Between the years of 1972 and 2012, 54 
patients were diagnosed with ameloblastoma. 
Fourteen patients were excluded because they had 
a follow-up lower than 12 months. From the 40 
cases included in the study, 52.5% were women and 
47.5% were men between the second and seventh 
decade of life. The patients’ ages ranged from 13 
to 66 years, with an average age of 34.9 years 
(table I). Most patients were white (77.5%) and the 
most frequent site was the posterior region of the 
mandible (90%). Maxilla presented only 2 cases 
(5%), both in posterior region.
Table I – Demographic charateristics
Gender
Female 21(52.5%)
Male 19 (47.5%)
Color
White 31 (77.5%)
Black 7 (18.4%)
Age
0-9 0
10-19 6 (15%)
20-29 9 (22.5%)
30-39 9 (22.5%)
40-49 10 (25%)
50-59 5 (12.5%)
60-69 1 (2.5%)
Forty-four patients had larger lesions with large 
involvement of the mandible region: body and angle 
(15.8%), body and ramus (18.4%), symphysis and 
body (5.3%), symphysis and ramus (2.6%); and one 
case with involvement of the right and left side of 
the mandible (2.6%) (table II).
All patients underwent surgical treatment, 
38 (95%) were subjected to a surgical treatment 
in the mandible, with resection of the lesion 
with peripheral osteotomy and 2 cases (5%) 
underwent surgery in the maxilla. The mandibular 
reconstruction, when indicated, was performed 
with microvascular fibular graft or iliac crest 
bone graft.
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Table II – Clinical characteristics of studied cases
Anatomical site Region (%) Treatment Recurrence
Mandible
(n = 38)
Body (42.1)
Radical surgery 5 (13,5%)
Angle (2.6)
Ramus (5.3)
Body and angle (15.8)
Body and ramus (18.4)
Symphysis and body (5.3)
Symphysis and ramus (2.6)
Right and left side of the mandible 
(2.6)
Maxilla
(n = 2) Posterior region (100) Radical Surgery 2(100%)
Five patients presented recurrence in the 
mandible, and both cases that occurred in the 
maxilla also relapsed. The time for recurrence 
ranged from 10 months to 9 years, with a mean of 
5.11 years. One patient, who had ameloblastoma in 
the maxilla, died from aggressiveness of the tumor 
and complications of the treatment. 
Discussion
The ameloblastoma is a benign tumor, locally 
aggressive, with odontogenic origin [25]. Most patients 
have between 30 and 60 years at time of diagnosis. 
Clinically, it is characterized by slow growth, painless 
enlargement and expansion involving the maxillary 
bones, leading to a facial deformity [18]. There is no 
predilection for sex [9]. In the present study gender 
distribution showed no preferences, as most reports 
in literature [1, 6-8, 21].  
The location of the tumor is related to the 
individual’s ethnicity, with the posterior region most 
frequently involved in Caucasian and Japanese; 
while in black, especially those of African origin, 
the anterior region is most common site of the 
disease [16]. This study had a high prevalence of 
white individuals.
Our study has identified that the mandible was 
the most affected site, posterior region with 36 cases 
(90%), the anterior with 2 cases (5%), which is in 
agreement with almost studies [4, 6, 8, 17].
The ameloblastoma is an odontogenic tumor 
with a strong tendency to recurrence after treatment 
[20]. There are many treatment protocols, the most 
appropriate being surgery. Cryotherapy, radiotherapy 
and chemotherapy are also reported, although the 
effectiveness of these procedures have not been 
established by controlled studies. Ameloblastomas 
inadequately treated enables greater chance of 
relapse [26]. 
It is believed that the recurrence rate is 
related to many factors such as tumor subtype, 
methods of t reatment and tumor behav ior 
[5]. Nakamura et al. compared the long-term 
results of 78 cases of ameloblastoma, obtained 
a recurrence rate of 7.1% after radical surgery 
and 33.3% after conservative treatment. They 
recommended wide jaw resection as the best 
treatment for ameloblastoma [13]. Our study had 
a 17.5% recurrence rate after radical surgical 
treatment.
Sassi et al. [24] evaluated 43 patients, 31 
who had no previous treatment were submitted to 
surgical treatment with a recurrence rate of 4 (13%) 
of cases. Of those who relapsed, 2 performed only 
partial resection, 1 curettage and cryotherapy; and 
1 wide resection. Lower recurrence rate is observed 
with radical surgical treatment.
According to Doenja Hertog et al.. [10] all 
patients in whom preoperative diagnosis of 
ameloblastoma was available were advised to radical 
surgery. However, in the 28 patients who were treated 
by enucleation, the recurrence rate reached about 
60% over a mean follow-up of 8.3 years. 
The reconstruction of large defects, caused by 
radical surgery with microvascular fibular graft 
favors patient in functional, aesthetic aspects 
for fast reintegration into society and minimize 
psychological effects arising from surgery [22]. 
Sassi et al.. [23] confirmed the successful 
outcome of the functional rehabilitation of the 
stomatognathic system with titanium cylinder 
implants in microvascular f ibular graft for 
reconstruction of mandible.
Ameloblastomas have a greater tendency to 
relapse when surgery is not performed properly, 
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with wide excision and margin of safety, thus, its 
treatment requires full resection with broad safety 
margin and immediate reconstruction whenever 
possible. The microvascular fibular graft is a 
good alternative for reconstruction of segments or 
even entire jaw, which restores the function, the 
aesthetics of the stomatognathic system, and allow 
implant-prosthetic rehabilitation.
In addition, it is recommended that a long 
period of clinical and radiographic follow-up, 
because recurrence may occur after a long period 
after treatment.
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